Bone and mineral disorders are common after organ transplantation. Osteoporosis post
transplantation is associated with increased morbidity and mortality. Pathogenesis of bone …

Autologous and allogeneic hematopoietic stem cell transplantation (HSCT) is the treatment
of choice for patients with some malignant and non-malignant hematological diseases …

Purpose The number of long-term survivors after hematopoietic stem-cell transplantation
(HSCT) for malignant and nonmalignant disorders is increasing, and late effects are gaining …

Annually,~ 50,000 patients undergo hematopoietic stem cell transplantation (HCT)
worldwide with almost 22,000 of these patients receiving HCT in the United States. HCT is a …

Current advances in medicine have revolutionized the field of regenerative medicine
dramatically with newly evolved therapies for repair or replacement of degenerating or …

Abstract In 1963 George Mathé announced to the world that he had cured a patient of
leukaemia by means of a bone-marrow transplant. Since than much progress has been …

Bone health disturbances commonly occur after hematopoietic cell transplantation (HCT)
with loss of bone mineral density (BMD) and avascular necrosis (AVN) foremost among …

Osteopenia and osteoporosis are common long-term complications of the cytotoxic
conditioning regimen for hematopoietic stem cell transplantation (HSCT). We examined …

Survival after allogeneic stem cell transplantation (allo-HSCT) has improved, but so have
long-term sequelae. We studied risk factors for fractures and impaired bone health in allo …

Context Bone loss and fractures are common and serious complications following
hematopoietic stem cell transplantation (HSCT), and identifying risk predictors for fractures …